TY - JOUR
T1 - Specific binding and clearance of [3H]dynorphin (1–13) in the perfused rat lung
T2 - an application of the multiple‐indicator dilution method
AU - SATO, HITOSHI
AU - TERASAKI, TETSUYA
AU - TSUJI, AKIRA
PY - 1990/12
Y1 - 1990/12
N2 - Abstract— The clearance and binding of a κ‐selective opioid peptide, dynorphin (1–13), in the perfused rat lung has been examined, using the multiple indicator dilution method. More than 50% of [3H]dynorphin (1–13) entering the pulmonary circulation was eliminated by the lung during a single passage of a tracer dose. By contrast, when a high dose (100 μM) of dynorphin (1–13) was concomitantly injected, [3H]dynorphin (1–13) behaved like [14C]sucrose, an extracellular marker. The kinetic analyses of the pulmonary venous outflow curves of [3H]dynorphin (1–13) and [14C]sucrose at low and high doses of dynorphin (1–13) indicated that the initial uptake rate constant, extraction ratio and distribution volume of [3H]dynorphin (1–13) decreased significantly in the presence of a high concentration of unlabelled dynorphin (1–13). These results suggest that [3H]dynorphin (1–13) is eliminated by a saturable process and binds to a specific binding site in the perfused lung, which may be the κ‐type binding site. The multiple indicator dilution technique, in combination with a moment analysis, was successfully applied to demonstrate the specific binding and clearance of dynorphin (1–13) in the perfused lung. 1990 Royal Pharmaceutical Society of Great Britain
AB - Abstract— The clearance and binding of a κ‐selective opioid peptide, dynorphin (1–13), in the perfused rat lung has been examined, using the multiple indicator dilution method. More than 50% of [3H]dynorphin (1–13) entering the pulmonary circulation was eliminated by the lung during a single passage of a tracer dose. By contrast, when a high dose (100 μM) of dynorphin (1–13) was concomitantly injected, [3H]dynorphin (1–13) behaved like [14C]sucrose, an extracellular marker. The kinetic analyses of the pulmonary venous outflow curves of [3H]dynorphin (1–13) and [14C]sucrose at low and high doses of dynorphin (1–13) indicated that the initial uptake rate constant, extraction ratio and distribution volume of [3H]dynorphin (1–13) decreased significantly in the presence of a high concentration of unlabelled dynorphin (1–13). These results suggest that [3H]dynorphin (1–13) is eliminated by a saturable process and binds to a specific binding site in the perfused lung, which may be the κ‐type binding site. The multiple indicator dilution technique, in combination with a moment analysis, was successfully applied to demonstrate the specific binding and clearance of dynorphin (1–13) in the perfused lung. 1990 Royal Pharmaceutical Society of Great Britain
UR - http://www.scopus.com/inward/record.url?scp=0025666752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025666752&partnerID=8YFLogxK
U2 - 10.1111/j.2042-7158.1990.tb07047.x
DO - 10.1111/j.2042-7158.1990.tb07047.x
M3 - Article
C2 - 1983155
AN - SCOPUS:0025666752
SN - 0022-3573
VL - 42
SP - 879
EP - 882
JO - Journal of Pharmacy and Pharmacology
JF - Journal of Pharmacy and Pharmacology
IS - 12
ER -